Nymox Pharmaceutical

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Nymox Pharmaceutical ( NYMX) is a biopharmaceutical company engaged in the research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease. This stock is trading up 15.8% to $7.25 in recent trading.

Today's Range: $6.45-$7.42

52-Week Range: $5.69-$9.50

Volume: 115,000

Three-Month Average Volume: 31,755

>>5 Stocks With Big Insider Buying

From a technical perspective, NYMX is exploding higher here right off its 50-day at $6.33 with above-average volume. This move has also started to push NYMX back above its 200-day at $7.22.

Traders should now look for long-biased trades in NYMX as long as it's trending above its 200-day at $7.22 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average action of 31,755 shares as bullish. If NYMX can sustain that trend, then this stock has a great chance of re-testing or possibly taking out its next major overhead resistance levels at $8.28 to $8.42. Any high-volume move above $8.40 will put $8.98 to $9.50 into focus for NYMX.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments